Metatranscriptome Analysis of the Vaginal Microbiota Reveals Potential Mechanisms for Protection against Metronidazole in Bacterial Vaginosis

ABSTRACT Bacterial vaginosis (BV) is a prevalent multifactorial disease of women in their reproductive years characterized by a shift from the Lactobacillus species-dominated microbial community toward a taxonomically diverse anaerobic community. For unknown reasons, some women do not respond to the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zhi-Luo Deng, Cornelia Gottschick, Sabin Bhuju, Clarissa Masur, Christoph Abels, Irene Wagner-Döbler
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2018
Materias:
Acceso en línea:https://doaj.org/article/b8f1728b8eb2419398b047479cdd44f1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b8f1728b8eb2419398b047479cdd44f1
record_format dspace
spelling oai:doaj.org-article:b8f1728b8eb2419398b047479cdd44f12021-11-15T15:24:22ZMetatranscriptome Analysis of the Vaginal Microbiota Reveals Potential Mechanisms for Protection against Metronidazole in Bacterial Vaginosis10.1128/mSphereDirect.00262-182379-5042https://doaj.org/article/b8f1728b8eb2419398b047479cdd44f12018-06-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mSphereDirect.00262-18https://doaj.org/toc/2379-5042ABSTRACT Bacterial vaginosis (BV) is a prevalent multifactorial disease of women in their reproductive years characterized by a shift from the Lactobacillus species-dominated microbial community toward a taxonomically diverse anaerobic community. For unknown reasons, some women do not respond to therapy. In our recent clinical study, among 37 women diagnosed with BV, 31 were successfully treated with metronidazole, while 6 still had BV after treatment. To discover possible reasons for the lack of response in those patients, we performed a metatranscriptome analysis of their vaginal microbiota, comparing them to the patients who responded. Seven of 8 clustered regularly interspaced short palindromic repeat (CRISPR)-associated (Cas) genes of Gardnerella vaginalis were highly upregulated in nonresponding patients. Cas genes, in addition to protecting against phages, might be involved in DNA repair, thus mitigating the bactericidal effect of DNA-damaging agents such as metronidazole. In the second part of our study, we analyzed the vaginal metatranscriptomes of four patients over 3 months and showed high in vivo expression of genes for pore-forming toxins in L. iners and of genes encoding enzymes for the production of hydrogen peroxide and d-lactate in L. crispatus. IMPORTANCE Bacterial vaginosis is a serious issue for women in their reproductive years. Although it can usually be cured by antibiotics, the recurrence rate is very high, and some women do not respond to antibiotic therapy. The reasons for that are not known. Therefore, we undertook a study to detect the activity of the complete microbiota in the vaginal fluid of women who responded to antibiotic therapy and compared it to the activity of the microbiota in women who did not respond. We found that one of the most important pathogens in bacterial vaginosis, Gardnerella vaginalis, has activated genes that can repair the DNA damage caused by the antibiotic in those women that do not respond to therapy. Suppressing these genes might be a possibility to improve the antibiotic therapy of bacterial vaginosis.Zhi-Luo DengCornelia GottschickSabin BhujuClarissa MasurChristoph AbelsIrene Wagner-DöblerAmerican Society for Microbiologyarticlebacterial vaginosisantibiotic resistancemetatranscriptomevaginal microbiotaMicrobiologyQR1-502ENmSphere, Vol 3, Iss 3 (2018)
institution DOAJ
collection DOAJ
language EN
topic bacterial vaginosis
antibiotic resistance
metatranscriptome
vaginal microbiota
Microbiology
QR1-502
spellingShingle bacterial vaginosis
antibiotic resistance
metatranscriptome
vaginal microbiota
Microbiology
QR1-502
Zhi-Luo Deng
Cornelia Gottschick
Sabin Bhuju
Clarissa Masur
Christoph Abels
Irene Wagner-Döbler
Metatranscriptome Analysis of the Vaginal Microbiota Reveals Potential Mechanisms for Protection against Metronidazole in Bacterial Vaginosis
description ABSTRACT Bacterial vaginosis (BV) is a prevalent multifactorial disease of women in their reproductive years characterized by a shift from the Lactobacillus species-dominated microbial community toward a taxonomically diverse anaerobic community. For unknown reasons, some women do not respond to therapy. In our recent clinical study, among 37 women diagnosed with BV, 31 were successfully treated with metronidazole, while 6 still had BV after treatment. To discover possible reasons for the lack of response in those patients, we performed a metatranscriptome analysis of their vaginal microbiota, comparing them to the patients who responded. Seven of 8 clustered regularly interspaced short palindromic repeat (CRISPR)-associated (Cas) genes of Gardnerella vaginalis were highly upregulated in nonresponding patients. Cas genes, in addition to protecting against phages, might be involved in DNA repair, thus mitigating the bactericidal effect of DNA-damaging agents such as metronidazole. In the second part of our study, we analyzed the vaginal metatranscriptomes of four patients over 3 months and showed high in vivo expression of genes for pore-forming toxins in L. iners and of genes encoding enzymes for the production of hydrogen peroxide and d-lactate in L. crispatus. IMPORTANCE Bacterial vaginosis is a serious issue for women in their reproductive years. Although it can usually be cured by antibiotics, the recurrence rate is very high, and some women do not respond to antibiotic therapy. The reasons for that are not known. Therefore, we undertook a study to detect the activity of the complete microbiota in the vaginal fluid of women who responded to antibiotic therapy and compared it to the activity of the microbiota in women who did not respond. We found that one of the most important pathogens in bacterial vaginosis, Gardnerella vaginalis, has activated genes that can repair the DNA damage caused by the antibiotic in those women that do not respond to therapy. Suppressing these genes might be a possibility to improve the antibiotic therapy of bacterial vaginosis.
format article
author Zhi-Luo Deng
Cornelia Gottschick
Sabin Bhuju
Clarissa Masur
Christoph Abels
Irene Wagner-Döbler
author_facet Zhi-Luo Deng
Cornelia Gottschick
Sabin Bhuju
Clarissa Masur
Christoph Abels
Irene Wagner-Döbler
author_sort Zhi-Luo Deng
title Metatranscriptome Analysis of the Vaginal Microbiota Reveals Potential Mechanisms for Protection against Metronidazole in Bacterial Vaginosis
title_short Metatranscriptome Analysis of the Vaginal Microbiota Reveals Potential Mechanisms for Protection against Metronidazole in Bacterial Vaginosis
title_full Metatranscriptome Analysis of the Vaginal Microbiota Reveals Potential Mechanisms for Protection against Metronidazole in Bacterial Vaginosis
title_fullStr Metatranscriptome Analysis of the Vaginal Microbiota Reveals Potential Mechanisms for Protection against Metronidazole in Bacterial Vaginosis
title_full_unstemmed Metatranscriptome Analysis of the Vaginal Microbiota Reveals Potential Mechanisms for Protection against Metronidazole in Bacterial Vaginosis
title_sort metatranscriptome analysis of the vaginal microbiota reveals potential mechanisms for protection against metronidazole in bacterial vaginosis
publisher American Society for Microbiology
publishDate 2018
url https://doaj.org/article/b8f1728b8eb2419398b047479cdd44f1
work_keys_str_mv AT zhiluodeng metatranscriptomeanalysisofthevaginalmicrobiotarevealspotentialmechanismsforprotectionagainstmetronidazoleinbacterialvaginosis
AT corneliagottschick metatranscriptomeanalysisofthevaginalmicrobiotarevealspotentialmechanismsforprotectionagainstmetronidazoleinbacterialvaginosis
AT sabinbhuju metatranscriptomeanalysisofthevaginalmicrobiotarevealspotentialmechanismsforprotectionagainstmetronidazoleinbacterialvaginosis
AT clarissamasur metatranscriptomeanalysisofthevaginalmicrobiotarevealspotentialmechanismsforprotectionagainstmetronidazoleinbacterialvaginosis
AT christophabels metatranscriptomeanalysisofthevaginalmicrobiotarevealspotentialmechanismsforprotectionagainstmetronidazoleinbacterialvaginosis
AT irenewagnerdobler metatranscriptomeanalysisofthevaginalmicrobiotarevealspotentialmechanismsforprotectionagainstmetronidazoleinbacterialvaginosis
_version_ 1718427973092114432